Sofie Møgelberg Knutzen

ORCID: 0000-0003-4760-9764
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sleep and related disorders
  • Cancer survivorship and care
  • Cancer-related cognitive impairment studies
  • Childhood Cancer Survivors' Quality of Life
  • Sleep and Wakefulness Research
  • Music Therapy and Health
  • Tryptophan and brain disorders
  • Cutaneous Melanoma Detection and Management
  • Intraperitoneal and Appendiceal Malignancies
  • Youth Substance Use and School Attendance
  • Management of metastatic bone disease
  • Circadian rhythm and melatonin
  • COVID-19 and Mental Health

Aarhus University Hospital
2023-2025

Aarhus University
2023-2025

Considering the persistent nature and higher prevalence of insomnia in cancer patients survivors compared with general population, there is a need for effective management strategies. This systematic review meta-analysis aimed to comprehensively evaluate available evidence efficacy pharmacological nonpharmacological interventions adult survivors.

10.1093/jncics/pkae041 article EN cc-by-nc-nd JNCI Cancer Spectrum 2024-04-30

Background: Up to 80% of patients experience late effects (LE) one year after surgery for peritoneal metastases (PM) from colorectal cancer (CRC). We tested the feasibility and outcome a treatment strategy address LEs. Methods: During January 2021-May 2023, who had undergone CRC-PM in Denmark were screened biopsychosocial LEs (anxiety, depression, fear recurrence, insomnia, cognitive impairment, pain, fatigue). Patients scoring according clinical cut-offs referred Multi-Disciplinary Team...

10.3390/cancers17071127 article EN Cancers 2025-03-27

Fear of cancer recurrence (FCR) is a distressing concern among survivors. Interventions to address FCR need be effective but also accessible and low cost. This randomized controlled trial evaluated the efficacy an online group-based psychological intervention for (ConquerFear-Group).Eligible breast (BC) survivors had completed primary treatment 3 months-5 years previously, were ≥18 years, scored ≥22 on Cancer Recurrence Inventory-Short Form (FCRI-SF). Participants ConquerFear-Group (focusing...

10.1002/pon.6193 article EN cc-by Psycho-Oncology 2023-07-25
Coming Soon ...